B. Metzler seel. Sohn & Co. AG acquired a new position in shares of Eastman Chemical Company (NYSE:EMN - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 31,795 shares of the basic materials company's stock, valued at approximately $2,130,000.
Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vise Technologies Inc. bought a new stake in Eastman Chemical during the second quarter worth about $265,000. OVERSEA CHINESE BANKING Corp Ltd bought a new position in Eastman Chemical in the 2nd quarter valued at about $803,000. Denali Advisors LLC increased its holdings in Eastman Chemical by 23.5% in the 2nd quarter. Denali Advisors LLC now owns 4,213 shares of the basic materials company's stock valued at $282,000 after buying an additional 803 shares during the period. Stevens Capital Partners acquired a new position in shares of Eastman Chemical in the 2nd quarter valued at approximately $336,000. Finally, Wealthfront Advisers LLC acquired a new position in shares of Eastman Chemical in the 2nd quarter valued at approximately $329,000. 83.65% of the stock is owned by institutional investors and hedge funds.
Eastman Chemical Price Performance
Shares of NYSE:EMN opened at $74.20 on Friday. The company has a market cap of $8.49 billion, a price-to-earnings ratio of 19.32, a PEG ratio of 0.91 and a beta of 1.06. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.50 and a quick ratio of 0.76. The firm has a 50 day simple moving average of $70.56 and a 200 day simple moving average of $72.67. Eastman Chemical Company has a one year low of $56.11 and a one year high of $83.47.
Eastman Chemical (NYSE:EMN - Get Free Report) last posted its earnings results on Thursday, July 30th. The basic materials company reported $1.97 earnings per share for the quarter, topping analysts' consensus estimates of $1.82 by $0.15. The firm had revenue of $2.51 billion for the quarter, compared to analysts' expectations of $2.40 billion. Eastman Chemical had a net margin of 4.99% and a return on equity of 9.46%. The company's revenue was up 9.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.60 earnings per share. Eastman Chemical has set its Q3 2026 guidance at 1.970-1.970 EPS. Research analysts predict that Eastman Chemical Company will post 6.5 earnings per share for the current fiscal year.
Eastman Chemical Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Tuesday, September 15th will be given a dividend of $0.84 per share. The ex-dividend date is Tuesday, September 15th. This represents a $3.36 dividend on an annualized basis and a yield of 4.5%. Eastman Chemical's payout ratio is currently 87.50%.
Wall Street Analyst Weigh In
Several research firms recently issued reports on EMN. Royal Bank Of Canada increased their price target on shares of Eastman Chemical from $69.00 to $74.00 and gave the stock a "sector perform" rating in a research report on Wednesday, August 5th. Weiss Ratings restated a "hold (c)" rating on shares of Eastman Chemical in a research report on Thursday, August 13th. JPMorgan Chase & Co. upped their target price on Eastman Chemical from $80.00 to $82.00 and gave the stock an "overweight" rating in a research note on Monday, May 4th. Morgan Stanley reduced their target price on Eastman Chemical from $83.00 to $79.00 and set an "overweight" rating on the stock in a report on Thursday, July 2nd. Finally, Citigroup decreased their price target on Eastman Chemical from $85.00 to $81.00 and set a "buy" rating on the stock in a research note on Monday, August 3rd. Seven investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $79.17.
Check Out Our Latest Report on Eastman Chemical
About Eastman Chemical
(
Free Report)
Eastman Chemical Company NYSE: EMN is a global specialty materials company that develops, manufactures and markets a broad range of advanced materials, chemicals and fibers. Its product portfolio spans performance additives, functional products, and engineered plastics designed to enhance the durability, appearance and performance of end products across diverse industries.
The company's main business activities include the production of specialty chemicals used in adhesives, coatings, building materials and consumer care applications, as well as high-performance plastics for packaging, automotive and electronics markets.
Featured Stories
Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical Company (NYSE:EMN - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Eastman Chemical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eastman Chemical wasn't on the list.
While Eastman Chemical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.